Development of Class IIa Bacteriocins as Therapeutic Agents

<table>A representation of class IIa bacteriocin leucocin A, with the YGNGV consensus sequence and an N-terminal disulfide bridge.</table>

International Journal of Microbiology

Figure 1: Development of Class IIa Bacteriocins as Therapeutic Agents 